Global Iron-Deficiency Anaemia Therapy Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
“Global Iron-Deficiency Anemia Therapy Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz. The global Iron-Deficiency Anemia Therapy market report has been segmented on the basis of therapeutic category, condition, distribution channel, and region.
Global Iron-Deficiency Anemia Therapy Market: Overview
Iron deficiency is one of the most common nutritional disorder across globe and accounts for approximately one-half of anemia cases worldwide. Iron is an essential element as it helps in balancing and maintaining proper physiologic functioning of human body. Anemia is associated with chronic fatigue, impaired cognitive function, and diminished well-being among individuals. The general line of treatment options includes oral and intravenous iron therapies.
Global Iron-Deficiency Anemia Therapy Market: Dynamics
Rising prevalence of iron-deficiency related disorders and increasing number of cases of haemodilution in pregnancy are major factor driving growth of the global iron-deficiency anemia therapy market. In addition, growing elderly population and rising cases of incidence of chronic diseases are another factor fueling growth of the global market.
Furthermore, changing lifestyle, increasing government funding’s, rising per person health care expenditure are also factors expected to drive revenue growth of the global market.
However, high cost of therapy and lack of awareness among developing regions are some factors expected to hamper growth of the global market.
Global Iron-Deficiency Anemia Therapy Market: Segment Analysis
On the basis of therapeutic type, parenteral iron therapy segment is expected to dominates the global market in terms of revenue growth over next ten years. This can be primarily attributed to rising adoption of parental route of drug administration due to higher effective rate. On the basis of end user, hospitals are expected to register high revenue growth on the next ten years
Global Iron-Deficiency Anemia Therapy Market: Trends
Various companies, research institutes and government are funding in order to carry out various R&D activities and clinical trials for development of effective treatment procedure for anemia is the major trends witnessed in the market.
Global Iron-Deficiency Anemia Therapy Market: Regional Analysis
Currently, market in North America accounts for major share in terms of revenue and is expected to lucrative growth over the forecast period. This is primarily attributed rising prevelance of lifestyle diseases. Asia Pacific market in anticipated to witness fastest growth in terms of revenue over the forecast period. In terms of revenue growth, market such as Latin America, Europe, and Middle East and Africa are expected to register average growth over the forecast period in the global market.
Global Iron-Deficiency Anemia Therapy Market Segmentation:
Segmentation by therapy type:
- Oral Iron Therapy
- Parenteral Iron Therapy
- Red Blood Cell Transfusion
- Other therapies
Segmentation by end user:
- Home Healthcare
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Allergan plc
- Akebia Therapeutics Inc.
- AMAG Pharmaceuticals, Inc.
- Keryx Biopharmaceuticals Inc.
- Johnson & Johnson
- Luitpold Pharmaceuticals Inc.
- Bayer AG
- Pharmacosmos A/S
- Apotex Inc.
- Luitpold pharmaceuticals Inc.
Request for TOC
Don't just take our word. We are trusted by these great companies!